Human Fibroblast Growth Factor 19 (FGF19) Protein

Este producto es parte de FGF19 - Fibroblast Growth Factor 19
Product Graph
234€ (5 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Fibroblast Growth Factor 19 (FGF19) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx262135
tested applications
SDS-PAGE

Description

Fibroblast Growth Factor 19 (FGF19) His Tag Protein is a recombinant cytokine.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Fibroblast Growth Factor 19 (FGF19)
Host
E. coli
Origin
Human
Conjugation
Unconjugated
Observed MW
Molecular Weight: 23 kDa
Tag: N-terminal His tag
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Purification
Purified by proprietary chromatographic techniques, followed by filtration (0.4 µm).
Size 1
5 µg
Size 2
25 µg
Size 3
1 mg
Form
Lyophilized Reconstitute in distilled water to a concentration of approximately 0.5 mg/ml. Allow the lyophilized pellet to dissolve completely before use. Sterile filtration is recommended prior to use in cell culture.
Tested Applications
SDS-PAGE
Buffer
Prior to lyophilization: 20 mM Tris, 20 mM NaCl, pH 7.5.
Availability
Shipped within 5-10 working days.
Storage
Stable at room temperature for up to 3 weeks. Store below -18 °C for long-term storage. Upon reconstitution, store at 4 °C for up to 7 days and store below -18 °C for long-term storage. For long-term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O95750
Gene ID
9965
OMIM
603891
Alias
FGF-19
Background
Protein FGF19
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

FGF19 is a metabolic hormone primarily produced in the ileum of the small intestine in response to bile acid signaling where it regulates bile acid homeostasis by suppressing cholesterol 7α-hydroxylase (CYP7A1) expression in the liver FGF19 also promotes glucose metabolism, lipid homeostasis, and energy expenditure through signaling pathways involving its receptor FGFR4 and the co-receptor β-Klotho Dysregulation of FGF19 has been linked to non-alcoholic fatty liver disease (NAFLD), insulin resistance, and obesity Elevated FGF19 levels are also observed in liver cancers such as hepatocellular carcinoma (HCC) where its overactivation promotes tumor growth by driving cell proliferation and survival FGF19 analogs are being explored as therapies for metabolic disorders, including type 2 diabetes and dyslipidemia

Related Products

EH0129

Human FGF19 (Fibroblast growth factor 19) ELISA Kit

Ver Producto
EP0241

Porcine FGF19 (Fibroblast growth factor 19) ELISA Kit

Ver Producto
ER0949

Rat FGF19 (Fibroblast Growth Factor 19) ELISA Kit

Ver Producto